Several classes of medications improve cardiovascular and kidney outcomes in patients with type 2 diabetes and CKD, including angiotensin-converting enzyme inhibitors (ACEi) [7], angiotensin receptor blockers (ARBs) [8], sodium-glucose cotransporter-2 inhibitors (SGLT2i) [9], and the non-steroidal mineralocorticoid receptor antagonist (MRA) finerenone [10, 11]
02 Performance Research Compounds studied for their biochemical mechanisms in performance-related research
Small air bubbles in the solution are normal and do not affect safety or efficacy
If your current medication isnt delivering the expected results, your provider can adjust your prescription at no additional cost
Keep a dated record of symptoms, treatments, and missed workdays
for Ozempic prescriptions, a trend driven by its residents determination to address obesity